NCT02608996View on ClinicalTrials.gov

Nesiritide in Hypertension

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2030

Conditions
Hypertension
Interventions
DRUG

Nesiritide

This intervention is designed to determine the optimal dose range of BNP for treatment of patients with uncontrolled hypertension

DRUG

Placebo

For comparison to elucidate the true effect of nesiritide

Trial Locations (3)

1478

RECRUITING

Akershus University Hospital, Strømmen

0424

NOT_YET_RECRUITING

Oslo University Hopital, Rikshospitalet, Oslo

0450

RECRUITING

Oslo University Hospital, Ullevål Hospital, Oslo

All Listed Sponsors
collaborator

University of Oslo

OTHER

collaborator

University Hospital, Akershus

OTHER

lead

Oslo University Hospital

OTHER